Oxurion NV (OXUR.BR) Stock Price

€0.162 4.7%

Sign up
to add to portfolio

AI Score

Sell
  • Alternative

    3
  • Fundamental

    2
  • Technical

    2

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Oxurion NV, AI stock picks, stock alerts and much more.

Sign up

OXUR.BR AI Stock Analysis

AI stock analysis for OXUR.BR is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Oxurion NV (OXUR.BR) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Oxurion NV (OXUR.BR) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Oxurion NV (OXUR.BR), currently trading at €0.162, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About OXUR.BR

LSE
  • Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally.

  • Symbol

    OXUR.BR

  • Market

    EURONEXT

  • Industry

    Biotechnology

  • Market Cap

    589412

Similar Stocks

VLA.PA Valneva SE
VLA.PA
€3.32
6.7%
3
TUB.BR Financière de Tubize SA
TUB.BR
€139.2
0.3%
5
OSE.PA OSE Immunotherapeutics SA
OSE.PA
€6.13
1.5%
5
UCB.BR UCB SA
UCB.BR
€178
0.8%
6
IPH.PA Innate Pharma S.A.
IPH.PA
€1.84
1.2%
2

OXUR.BR Alternative Data

Web Traffic

Oxurion NV receives an estimated 117 monthly visitors to oxurion.com.

  • Web Traffic

    117

  • Change from Previous Month

    25.5%

  • 3 Month Change

    90.4%

  • YoY Change

    90.4%

News Mentions

Oxurion NV was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Youtube Subscribers

Oxurion NV has 18 subscribers on its main Youtube channel.

  • Youtube Subscribers

    18

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Job Postings

Oxurion NV currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Employees

According to LinkedIn, Oxurion NV has 34 employees.

  • LinkedIn Employees

    34

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    6.3%

Reddit Mentions

Oxurion NV has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

OXUR.BR Financials

OXUR.BR Key Metrics
  • Total Revenue

    €1K

  • Net Income

    -€3M

  • Earnings per Share

    -€0.0025

  • Free cash flow

    -€1.8M

  • EBITDA

    -€2.3M

  • EBITDA Ratio

    -2300

  • Total Assets

    €4.6M

OXUR.BR 2-year Revenue & Income
OXUR.BR 2-year Free Cash Flow

OXUR.BR Technicals

OXUR.BR SMA
OXUR.BR RSI

FAQ

What's the current price of Oxurion NV (OXUR.BR) Stock?
The price of an Oxurion NV (OXUR.BR) share is €0.162.

What's the market cap of Oxurion NV?
The current market cap of Oxurion NV is 589412.

Should I buy or sell OXUR.BR?
Oxurion NV exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Oxurion NV a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Oxurion NV stock. There are several bearish signals and market challenges that could negatively impact Oxurion NV's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Oxurion NV (OXUR.BR) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Oxurion NV stock right now, as the outlook appears bearish.

What are some stocks similar to Oxurion NV (OXUR.BR) that investors often compare it to?
Oxurion NV (OXUR.BR) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..

What is the forecast for Oxurion NV's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Oxurion NV's stock price to be around €0.145 in 2026. Starting from the current price of €0.162, this represents a 10.5% change in price, indicating a bearish outlook for the stock.

How to buy Oxurion NV (OXUR.BR) Stock?
Oxurion NV stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Oxurion NV shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.